Extracellular vesicle markers in relation to obesity and metabolic complications in patients with manifest cardiovascular disease
Mariëtte E.G. Kranendonk(Princess Máxima Center), Frank L.J. Visseren(University Medical Center Utrecht), Gerard Pasterkamp(University Medical Center Utrecht), Danny A Kanhai(University Medical Center Utrecht), Yolanda van der Graaf(SUNY Downstate Health Sciences University), Cuno S.P.M. Uiterwaal(University Medical Center Utrecht), Eric Kalkhoven(Utrecht University), Dominique PV de Kleijn(Utrecht University)
Cited by 130
Related Papers
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice
|European Heart Journal|2021|6.1k
From Vulnerable Plaque to Vulnerable Patient
|Circulation|2003|2.7k
From Vulnerable Plaque to Vulnerable Patient
|Circulation|2003|2.3k
Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel
|European Heart Journal|2020|1.5k
Simvastatin with or without Ezetimibe in Familial Hypercholesterolemia
|New England Journal of Medicine|2008|1.2k